Patient Name : MS.
SUNITA DUGAR Scan to Validate Collection Time : 02/06/2025, 06:23 PM
Age / Gender : 43 years / Female Receiving Time : 02/06/2025, 06:46 PM
Patient ID : 20633 Reporting Time : 02/06/2025, 07:32 PM
Organisation Name : Petals Women's Clinic Sample ID :
Ref. Doctor : Dr. SMITA GUTGUTIA 002715325
Department Of IMMUNOLOGY
Test Description Value(s) Units Reference Range
CA 125
CA 125 14.44 U/mL 0 - 35
Method : Serum, CLIA
Interpretation:
Useful for: Evaluating patients' response to ovarian cancer therapy, predicting recurrent ovarian cancer.
Elevated serum CA 125 levels are seen in mostly women with ovarian cancer. It has also been reported in certain non-ovarian malignancies and in benign
conditions like cirrhosis, hepatitis, endometriosis, first trimester pregnancy, ovarian cysts, and pelvic inflammatory disease. Elevated levels during the
menstrual cycle also have been reported.
Limitations:
Results cannot be interpreted as absolute evidence of the presence or absence of disease.Serum markers are not specific for malignancy and values may
vary by method. Values obtained with different assay methods cannot be used interchangeably.
**END OF REPORT**
Checked By : Arijit Sen Sarma
Page 1 of 8
Patient Name : MS. SUNITA DUGAR Scan to Validate Collection Time : 02/06/2025, 06:23 PM
Age / Gender : 43 years / Female Receiving Time : 02/06/2025, 08:24 PM
Patient ID : 20633 Reporting Time : 02/06/2025, 08:25 PM
Organisation Name : Petals Women's Clinic Sample ID :
Ref. Doctor : Dr. SMITA GUTGUTIA 002715325
Department Of CLINICAL PATHOLOGY
Test Description Value(s) Units Reference Range
Urine RE
Physical Examination
Quantity 50 ml -
Colour* Pale Yellow Pale Yellow
Appearance Slightly Hazy Clear
Deposit* Present Absent
Chemical Examination
Sugar Absent Absent
Protein (Albumin) Absent Absent
Sp.Gravity 1.010 1.010 - 1.030
Reaction Acidic(6.0)
Urine Ketones (Acetone)* Absent Absent
Bile pigments* Absent Absent
Blood* Absent Absent
Urobilinogen* Normal Normal
Microscopic Examination Urine
Pus Cells (WBCs)* 3-4 /hpf 0-5
Epithelial Cells* 2-3 /hpf 0-4
Red blood Cells* Absent /hpf Absent
Cast* Absent Absent
Crystals* Absent Absent
Bacteria* Absent Absent
Microorganism Absent Absent
OTHERS : Absent Absent
**END OF REPORT**
Checked By : Arijit Sen Sarma
Page 2 of 8
Patient Name : MS. SUNITA DUGAR Scan to Validate Collection Time : 02/06/2025, 06:23 PM
Age / Gender : 43 years / Female Receiving Time : 02/06/2025, 06:46 PM
Patient ID : 20633 Reporting Time : 02/06/2025, 07:32 PM
Organisation Name : Petals Women's Clinic Sample ID :
Ref. Doctor : Dr. SMITA GUTGUTIA 002715325
Department Of IMMUNOLOGY
Test Description Value(s) Units Reference Range
TSH (Thyroid Stimulating Hormone)
TSH 3.13 µIU/mL Children :
Method : CLIA, Sample Type : Serum Birth - 4 D : 1.0 - 39.0
2 - 20 wk : 1.7 -9.1
21 wk - 20 y : 0.7 - 6.4
Adult
21 - 54 Y : 0.4 - 4.2
55 - 87 Y : 0.5 - 8.9
Pregnancy :
First Trimester : 0.3 - 4.5
Second Trimester : 0.5 - 4.6
Third Trimester :0.8 - 5.2
Interpretation
1. TSH results between 4.5 to 15 show considerable physiologic & seasonal variation, suggest clinical correlation or repeat testing with fresh sample .
2. TSH results between 0.1 to 0.45 require correlation with patient age & clinical symptoms. As with increasing age, there are marked changes in thyroid
hormone production, metabolism & its actions resulting in an increased prevalence of subclinical thyroid disease .
3. TSH values may be transiently altered because of non thyroidal illness like severe infections,liver disease, renal and heart failure,severe burns, trauma
and surgery etc .
4. Drugs that decrease TSH values e.g:L-dopa,Glucocorticoid Drugs that increase TSH values e.g Iodine,Lithium,Amiodarone.
Note: Patients on Biotin supplement may have interference in some immunoassays. With individuals taking high dose Biotin (more
than 5 mg per day) supplements, at least 8-hour wait time before blood draw is recommended.
Ref: Arch Pathol Lab Med—Vol 141, November 2017
INSTRUMENT USES : FULLY AUTOMATED ANALYZER, SIEMENS ADVIA CENTAUR CP.
**END OF REPORT**
Tests marked with NABL symbol are accredited by NABL vide Certificate no MC - 6083
Checked By : Arijit Sen Sarma
Page 3 of 8
Patient Name : MS. SUNITA DUGAR Scan to Validate Collection Time : 02/06/2025, 06:23 PM
Age / Gender : 43 years / Female Receiving Time : 02/06/2025, 06:46 PM
Patient ID : 20633 Reporting Time : 02/06/2025, 08:18 PM
Organisation Name : Petals Women's Clinic Sample ID :
Ref. Doctor : Dr. SMITA GUTGUTIA 002715325
Department Of BIOCHEMISTRY
Test Description Value(s) Units Reference Range
HbA1C (Glycated hemoglobin)
Glyco Hb (HbA1C) 5.1 % 4.0-5.6 - Normal
Method : EDTA Whole blood,HPLC 5.7-6.4 -Pre Diabetes
>6.5 - Diabetes
Estimated Average Glucose : 99.67 mg/dL
• Adapted from American Diabetes Association (ADA-2022)
Comment :
Estimated Average Glucose (eAG) is a new way to understand how well you are managing your diabetes. Using eAG may help you get a better idea of how well you are taking care of your diabetes. And that
can help you and your health care provider know what changes you may need to make to be as healthy as possible.
HbA1c % 5 5.5 6 6.5 7 7.5 8 8.5 9 10 11 12
(eAG)
97 111 126 140 154 169 183 197 212 240 269 298
mg/dL
• The HbA1c goal for people with diabetes is less than 7 percent. A 3 to 6 monthly monitoring is recommended in diabetics. People with diabetes should get the test done more often if their blood sugar
stays too high or if their healthcare provider makes any change in the treatment plan. HbA1c concentration represents the integrated values for blood glucose over the preceding 6 -10 wks and is not
affected by daily glucose fluctuation, exercise & recent food intake. It is a more useful tool for clinical management of Diabetes mellitus through routine monitoring & assesses compliance with therapeutic
regimen.
• In cases of Haemoglobinopathies, HbA1c values should not be used for diagnosis of Diabetes or for evaluating glycemic control.
• The assay is not intended for analyzing specimens from patients with THb levels < 7 or > 23 g/dL
Instrument : Test done by BIO-RAD D-10 High Performance Liquid Chromatography (HPLC).
Graph :
Tests marked with NABL symbol are accredited by NABL vide Certificate no MC - 6083
Checked By : Arijit Sen Sarma
Page 4 of 8
Patient Name : MS. SUNITA DUGAR Scan to Validate Collection Time : 02/06/2025, 06:23 PM
Age / Gender : 43 years / Female Receiving Time : 02/06/2025, 06:46 PM
Patient ID : 20633 Reporting Time : 02/06/2025, 08:18 PM
Organisation Name : Petals Women's Clinic Sample ID :
Ref. Doctor : Dr. SMITA GUTGUTIA 002715325
Department Of BIOCHEMISTRY
Test Description Value(s) Units Reference Range
Tests marked with NABL symbol are accredited by NABL vide Certificate no MC - 6083
Checked By : Arijit Sen Sarma
Page 5 of 8
Patient Name : MS. SUNITA DUGAR Scan to Validate Collection Time : 02/06/2025, 06:23 PM
Age / Gender : 43 years / Female Receiving Time : 02/06/2025, 06:46 PM
Patient ID : 20633 Reporting Time : 02/06/2025, 08:18 PM
Organisation Name : Petals Women's Clinic Sample ID :
Ref. Doctor : Dr. SMITA GUTGUTIA 002715325
Department Of BIOCHEMISTRY
Test Description Value(s) Units Reference Range
**END OF REPORT**
Tests marked with NABL symbol are accredited by NABL vide Certificate no MC - 6083
Checked By : Arijit Sen Sarma
Page 6 of 8
Patient Name : MS. SUNITA DUGAR Scan to Validate Collection Time : 02/06/2025, 06:23 PM
Age / Gender : 43 years / Female Receiving Time : 02/06/2025, 06:46 PM
Patient ID : 20633 Reporting Time : 02/06/2025, 09:55 PM
Organisation Name : Petals Women's Clinic Sample ID :
Ref. Doctor : Dr. SMITA GUTGUTIA 002715325
Department Of HAEMATOLOGY
Test Description Value(s) Units Reference Range
CBC ESR
Hemoglobin (Hb) 12 gm/dL 11.5 - 17
Method : Cynmeth Photometric Measurement
Erythrocyte (RBC) Count 3.73 10^6/uL 3.8 - 6
Method : Electrical Impedence
Packed Cell Volume (PCV) 33.7 % 35 - 52
Method : Calculated
Mean Cell Volume (MCV) 90.3 um^3 76 - 100
Method : Electrical Impedence
Mean Cell Haemoglobin (MCH) 32.2 pg 27 - 34
Method : Calculated
Mean Corpuscular Hb Concn. (MCHC) 35.6 gm/dL 32 - 35
Method : Calculated
Red Cell Distribution Width (RDW-CV) 13.6 % 11 - 17
Method : Electrical Impedence
Total Leucocytes Count WBC 6.74 10^3/Ul 4.0-11
Method : Electrical Impedence
Neutrophils 55 % 40 - 73
Method : VCsn Technology
Lymphocytes 35 % 15 - 45
Method : VCsn Technology
Monocytes 03 % 2 - 12
Method : VCsn Technology
Eosinophils 07 % 0.5 - 7
Method : VCsn Technology
Basophils 00 % 0-2
Method : VCsn Technology
Absolute Neutrophil Count 3.71 10^3/ul 2.0 - 7.0
Method : Calculated
Absolute Lymphocyte Count 2.36 10^3/ul 1-3
Method : Calculated
Absolute Monocyte Count 0.20 10^3/ul 0.2-1.0
Method : Calculated
Absolute Eosinophil Count 0.47 10^3/ul 0.0-0.5
Method : Calculated
Checked By : Supriyo Maity
Page 7 of 8
Patient Name : MS. SUNITA DUGAR Scan to Validate Collection Time : 02/06/2025, 06:23 PM
Age / Gender : 43 years / Female Receiving Time : 02/06/2025, 06:46 PM
Patient ID : 20633 Reporting Time : 02/06/2025, 09:55 PM
Organisation Name : Petals Women's Clinic Sample ID :
Ref. Doctor : Dr. SMITA GUTGUTIA 002715325
Department Of HAEMATOLOGY
Test Description Value(s) Units Reference Range
Absolute Basophils Count 00 10^3/ul 0-2
Method : Calculated
Platelet Count 298 10^3/ul 150 - 450
Method : Electrical Impedence
Mean Platelet Volume (MPV) 10.1 fL 7.2 - 11.7
Method : Electrical Impedence
PCT 0.3 % 0.2 - 0.5
Method : Calculated
PDW 17.4 % 9.0 - 17.0
Method : Calculated
RBC Normocytic -
normochromic
WBC Within normal limits
Platelet Adequate on smear
ESR - Erythrocyte Sedimentation Rate 25 mm/hr <20
Method : Westergren
Tests done on Automated Five Part Cell Counter. (WBC, RBC,Platelet count by impedance method, colorimetric method for Hemoglobin, WBC differential by flow cytometry using laser technology other
parameters are calculated). All Abnormal Haemograms are reviewed confirmed microscopically.
**END OF REPORT**
Checked By : Supriyo Maity
Page 8 of 8
